Physician Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Physician Wealth Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$861K	Buy	3,392 +63	+2%	+$14.7K	0.1%	90
2026 Q1	$814K	Buy	3,329 +181	+6%	+$42.2K	0.11%	78
2025 Q4	$651K	Sell	3,148 -578	-16%	-$114K	0.09%	88
2025 Q3	$691K	Buy	3,726 +684	+22%	+$117K	0.1%	84
2025 Q2	$465K	Sell	3,042 -278	-8%	-$42.7K	0.07%	101
2025 Q1	$551K	Buy	3,320 +5	+0.2%	+$782	0.09%	89
2024 Q4	$479K	Sell	3,315 -341	-9%	-$52.8K	0.08%	100
2024 Q3	$600K	Sell	3,656 -403	-10%	-$64.2K	0.11%	82
2024 Q2	$613K	Sell	4,059 -148	-4%	-$22K	0.11%	83
2024 Q1	$608K	Sell	4,207 -821	-16%	-$131K	0.13%	83
2023 Q4	$817K	Buy	5,028 +18	+0.4%	+$2.76K	0.18%	68
2023 Q3	$794K	Buy	5,010 +5	+0.1%	+$825	0.2%	60
2023 Q2	$818K	Buy	5,005 +1,373	+38%	+$222K	0.2%	60
2023 Q1	$590K	Buy	3,632 +5	+0.1%	+$807	0.15%	67
2022 Q4	$610K	Sell	3,627 -45	-1%	-$7.77K	0.16%	66
2022 Q3	$606K	Sell	3,672 -33	-0.9%	-$5.58K	0.19%	64
2022 Q2	$644K	Sell	3,705 -15	-0.4%	-$2.67K	0.19%	65
2022 Q1	$670K	Sell	3,720 -15	-0.4%	-$2.55K	0.18%	68
2021 Q4	$650K	Buy	3,735 +85	+2%	+$13.9K	0.17%	73
2021 Q3	$589K	Buy	3,650 +4	+0.1%	+$682	0.16%	80
2021 Q2	$620K	Sell	3,646 -5	-0.1%	-$828	0.18%	74
2021 Q1	$597K	Buy	3,651 +3	+0.1%	+$485	0.19%	69
2020 Q4	$605K	Sell	3,648 -71	-2%	-$10.5K	0.21%	68
2020 Q3	$516K	Buy	3,719 +4	+0.1%	+$592	0.21%	66
2020 Q2	$550K	Buy	3,715 +109	+3%	+$15.9K	0.22%	66
2020 Q1	$552K	Buy	3,606 +432	+14%	+$61.3K	0.28%	52
2019 Q4	$462K	Buy	3,174 +30	+1%	+$4.07K	0.21%	64
2019 Q3	$431K	Buy	+3,144	New	+$414K	0.21%	64

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Physician Wealth Advisors's JNJ Position: Q2 2026 in Review

Physician Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, buying an estimated $14.7K and bringing the position to 3,392 shares worth $861K. The position accounts for 0.1% of the portfolio, ranked #90.

Physician Wealth Advisors first reported a position in JNJ in Q3 2019 and has held it in 28 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Physician Wealth Advisors held 3,392 shares of Johnson & Johnson worth $861K as of Q2 2026.
Physician Wealth Advisors bought 63 Johnson & Johnson shares in Q2 2026, an estimated $14.7K.
Johnson & Johnson made up 0.1% of Physician Wealth Advisors's portfolio in Q2 2026, its #90 holding.
Physician Wealth Advisors first reported a position in Johnson & Johnson in Q3 2019 and has held it in 28 quarters since.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.